NACDS letter builds on previous comments submitted by NACDS in 2018; demonstrates pharmacies’ essential role in improving the health and wellness of the nation, in alignment with Healthy People Objectives.
Through the engagement of the membership, NACDS brought its pro-patient and pro-pharmacy perspective to the IRA during its Congressional consideration and continues to shape the IRA during its implementation.
New PREP Act amendment issued today reflects strong and consistent urging of NACDS.
Article published in Johns Hopkins’ peer-reviewed Health Security journal follows a compelling announcement by the Biden Administration that gives states a window for action.
Two major patient-access victories in one week as government acts on NACDS’ recommendations.
Anticipated PREP Act amendment reflects strong and consistent urging of NACDS.
NACDS President and CEO Steven C. Anderson issued the following statement, upon the release of a U.S. Department of Health and Human Services (HHS) Fact Sheet describing decision-making underway about implications of the May 11, 2023, expiration of the current Public Health Emergency (PHE).
With the U.S. House of Representatives slated to consider legislation related to the pandemic this week, NACDS has an important message: constituents view the importance of pharmacy access as a lesson that must be learned from the past three years.
NACDS details actions needed by Biden Administration and Congress to prevent forced rollback
Sustaining PREP Act pharmacy flexibilities through October 2024 will help keep patients and pharmacies from having to “guess” about issues related to pharmacy access.
